Although most pregnancies result in a good outcome, complications are not uncommon and can be associated with serious implications for mothers and babies. Predictive modeling has the potential to improve outcomes through a better understanding of risk factors, heightened surveillance for high-risk patients, and more timely and appropriate interventions, thereby helping obstetricians deliver better care. We identify and study the most important risk factors for four types of pregnancy complications: (i) severe maternal morbidity, (ii) shoulder dystocia, (iii) preterm preeclampsia, and (iv) antepartum stillbirth. We use an Explainable Boosting Machine (EBM), a high-accuracy glass-box learning method, for the prediction and identification of important risk factors. We undertake external validation and perform an extensive robustness analysis of the EBM models. EBMs match the accuracy of other black-box ML methods, such as deep neural networks and random forests, and outperform logistic regression, while being more interpretable. EBMs prove to be robust. The interpretability of the EBM models reveal surprising insights into the features contributing to risk (e.g., maternal height is the second most important feature for shoulder dystocia) and may have potential for clinical application in the prediction and prevention of serious complications in pregnancy.
Keyphrases
- risk factors
- pregnancy outcomes
- neural network
- birth weight
- gestational age
- preterm birth
- pregnant women
- end stage renal disease
- transcription factor
- ejection fraction
- healthcare
- chronic kidney disease
- newly diagnosed
- early onset
- low birth weight
- deep learning
- body mass index
- palliative care
- physical activity
- machine learning
- prognostic factors
- climate change
- binding protein
- gene expression
- rotator cuff
- adipose tissue
- pain management
- patient reported outcomes
- weight gain
- quality improvement
- risk assessment
- type diabetes
- dna methylation
- glycemic control
- chronic pain
- preterm infants
- genome wide
- skeletal muscle
- insulin resistance
- affordable care act